Much Ado About Something: The Clinical Pattern of Tolvaptan-Associated Liver Injury in Participants With ADPKD

Am J Kidney Dis. 2023 Mar;81(3):259-260. doi: 10.1053/j.ajkd.2022.10.004. Epub 2022 Dec 16.

Authors

Merve Postalcioglu¹, Giuseppe Cullaro², Meyeon Park³

Affiliations

¹ Divisions of Nephrology, Department of Medicine, University of California-San Francisco, San Francisco, California.
² Gastroenterology and Hepatology, Department of Medicine, University of California-San Francisco, San Francisco, California.
³ Divisions of Nephrology, Department of Medicine, University of California-San Francisco, San Francisco, California. Electronic address: meyeon.park@ucsf.edu.

PMID: 36528464
DOI: 10.1053/j.ajkd.2022.10.004

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antidiuretic Hormone Receptor Antagonists
Humans
Liver
Polycystic Kidney, Autosomal Dominant*
Tolvaptan

Substances

Tolvaptan
Antidiuretic Hormone Receptor Antagonists

Grants and funding